Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × HER2-positive Gastric Cancer × Tegafur × Clear all

Phase

Status

Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4 Uterine Cervical Neoplasms 1 Pancreatic Neoplasms 1 HER2-positive Gastric Cancer 1 Efficacy and Safety 1

Interventions

Trastuzumab 2 Oxaliplatin 2 disitamab vedotin 1 Tegafur 1 Fluorouracil 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06439550 2024-06-03

Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC

The First Affiliated Hospital of Zhengzhou University

Phase 2 Not yet recruiting

Gastrointestinal

HER2-positive Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡